Equillium
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Equillium and other ETFs, options, and stocks.About EQ
Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6.
CEOBruce D. Steel
CEOBruce D. Steel
Employees35
Employees35
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2017
Founded2017
Employees35
Employees35
EQ Key Statistics
Market cap91.34M
Market cap91.34M
Price-Earnings ratio-2.37
Price-Earnings ratio-2.37
Dividend yield—
Dividend yield—
Average volume1.13M
Average volume1.13M
High today$1.71
High today$1.71
Low today$1.46
Low today$1.46
Open price$1.71
Open price$1.71
Volume1.03M
Volume1.03M
52 Week high$2.35
52 Week high$2.35
52 Week low$0.27
52 Week low$0.27
Stock Snapshot
With a market cap of 91.34M, Equillium(EQ) trades at $1.50. The stock has a price-to-earnings ratio of -2.37.
As of 2025-12-27, Equillium(EQ) stock has fluctuated between $1.46 and $1.71. The current price stands at $1.50, placing the stock +2.7% above today's low and -12.3% off the high.
Equillium(EQ) shares are trading with a volume of 1.03M, against a daily average of 1.13M.
In the last year, Equillium(EQ) shares hit a 52-week high of $2.35 and a 52-week low of $0.27.
In the last year, Equillium(EQ) shares hit a 52-week high of $2.35 and a 52-week low of $0.27.
People also own
Based on the portfolios of people who own EQ. This list is generated using Robinhood data, and it’s not a recommendation.